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The original cohort 
The original Lothian Birth Cohorts of 1921 (LBC1921) and 1936 (LBC1936) were designed 
as follow-up studies to the Scottish Mental Surveys of 1932 (SMS1932) and 1947 
(SMS1947), respectively [1]. The SMS1932 took place simultaneously across schools in 
Scotland on June 1st 1932, and used the Moray House Test (No. 12; MHT) of general 
intelligence. Almost every child attending school born in 1921 (N = 87,498) was tested [2]. 
The same MHT was administered to almost every child born in 1936 and attending school on 
June 4th 1947 for the SMS1947 (N = 70,805) [3]. As described in the cohorts profile 
published in 2012 [4], decades later, participants of both Surveys, mostly living in Edinburgh 
and the surrounding area (the Lothians) in older age, were invited to participate in the Lothian 
Birth Cohort (LBC) studies. Between 1999 and 2001, 550 of the SMS1932 were recruited to 
Wave 1 of the LBC1921 study, at a mean age of 79 years. Between 2004 and 2007, 1091 
members of SMS1947 were recruited to the Wave 1 of the LBC1936 study at a mean age of 
70 years. Both cohorts re-sat the MHT at initial follow-up. In addition, a large amount of 
other cognitive, psycho-social, lifestyle, medical, biomarker, genetic, brain imaging, and other 
data were collected. There are baseline protocol articles for LBC1921 [5] and LBC1936 [6], 
and a separate baseline brain imaging protocol article for LBC1936 [7]. 
 
What is the reason for the new data collection? 
There are two main reasons for the profile update. First, there have been new waves of data 
collection since the LBCs’ profiles were reported [4]. Second, there have been many new 
types of data collected. 
 
New waves of data collection. The LBC studies set out principally to examine the nature and 
determinants of non-pathological cognitive ageing from childhood to older age, and within in 
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older age [5]. Waves of testing have been conducted at roughly 3-yearly intervals since 
inception: the LBC1921 have been followed-up five times, from age 79 to age 92 years [8-
11]; and the LBC1936 have been followed-up four times from age 70 to age 79 years [6,9,11]. 
A fifth wave of the LBC1936 study started in autumn 2017 and tests the LBC1936 
participants in their early 80s. New waves of data collection since the LBCs’ profiles were 
published in 2012 (LBC1921 Waves 4 & 5; LBC1936 Waves 3 & 4), have been conducted 
during key periods of ageing, where the risk of onset of cognitive impairment and dementia is 
increased. Consequently, the scope of the studies has extended to identifying more risk and 
protective factors that have the potential to be interventions to reduce the risk of cognitive 
loss in later life. Although the major focus remains on cognitive and brain outcomes, 
advancements in knowledge and technology since 2012—and the diverse range of data 
collected from the participants—have resulted in opportunities for new variables and data 
collection methods to be adopted, and have allowed for aspects of ageing to be examined 
beyond those for which core grant funding was obtained. 
 
New types of data collected. A major reason for the profile update is the huge amount of new 
types of data collected on the LBCs since their profile [4] was published, especially: whole 
genome sequencing, longitudinal DNA methylation, longitudinal gene expression, lipidomics, 
post-mortem brain tissue, induced pluripotent stem cells (iPSC), inflammatory markers, 
oxidative stress markers, life-course geographical information, objectively-measured physical 
activity and sedentary behaviour, and dementia ascertainment. 
 
What will be the new areas of research? 
These correspond to the two reasons for the profile update listed in the previous section. First, 
the availability of 5 waves of consistently-measured cognitive, bio-medical, brain imaging, 
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psychosocial, lifestyle and other data in the LBC1921 and 4 waves of such data in the 
LBC1936 mean that longitudinal analyses are possible, covering the age ranges 79-92, and 
70-79, respectively. The numbers of waves means that non-linear effects can now be 
explored, and that the combined cohorts’ data cover most of the period we think of as older 
age in humans. 
 
The last paragraph of the previous section makes clear the new types of exposures, outcomes, 
and experimental models that are newly possible with the LBCs’ updated data. Thus, for 
example: longitudinal methylomics and transcriptomics research is now possible; 
geographical exposures such as green space and pollution are available as life-course 
exposures; and the studies can be extended from their previous focus on non-pathological 
cognitive ageing to dementias. The bank of cells for pluripotent stem cell formation (some 
have already been re-programmed) are available for experimental research on ageing, backed 
up with rich phenotyping and genotyping. The growing brain tissue bank allows a wide range 
of research on post-mortem tissue, linked with the phenotypic and genetic data. There is a 
protocol paper for the post-mortem brain tissue collection, preparation, and experimental 
work [12]. 
 
Wave 4 of the LBC1936 was timed carefully, so that the participants had the same mean and 
SD of age as the LBC1921 participants at Wave 1. By luck, the numbers of participants is 
identical, N = 550 for each (i.e., LBC1921 at Wave 1 and LBC1936 at Wave 4). This provides 
new possibilities for studying cohort effects on ageing, because the same data have been 
collected on people of the same age, but who were born 15 years apart. 
 
 
Cohort profile update: Lothian Birth Cohorts   5 
Who is in the cohort? 
Table 1 and Table 2 summarise the waves of assessment for LBC1921 and LBC1936, with 
details of mean age, numbers, sample composition, and data types collected at each wave. 
Flowcharts, with numbers of participants tested and reasons for attrition at each wave are 
presented in Figure 1 (for LBC1921) and Figure 2 (for LBC1936).  Of the original 550 
LBC1921 participants, 59 ‘completers’ have participated in all waves, including the most 
recent follow-up at mean age 92 (Wave 5) between April and December of 2013. Of the 
original 1091 LBC1936 participants, 550 ‘completers’ have participated in all waves, 
including the most recent follow-up at mean age 79 (Wave 4) between November 2014 and 
February 2017. Only a small number of participants in each cohort have missed a wave of 
testing but returned for subsequent waves (max n = 11). Rates of attrition between waves in 
the LBC1936 has been consistently ~20%, though in the older LBC1921 cohort they have 
varied from ~27 to 54%. For both cohorts, between most waves, the major causes of attrition 
have been death (up to 64% of non-attendees) and permanent withdrawal resulting from ill 
health and chronic incapacity (up to 67% of non-attendees).  
-(Table 1 here)- 
-(Table 2 here)- 
-(Figure 1 here)- 
-(Figure 2 here)- 
With regard to how attrition affects key variables, the differences between the tested sample at 
each wave and those who dropped out between waves of each study are shown for the first 
time in Table 3 (LBC1921) and Table 4 (LBC1936).  By wave, compared to those who 
remained in the LBC1921 study at Waves 1 to 5, participants who dropped out had: 
significantly lower older-age IQ scores at Wave 1 (p < 0.001), Wave 2 (p = 0.004), and Wave 
3 ( p = 0.02); lower Mini-Mental State Examination (MMSE) scores at Waves 1 – 4 (all p 
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values < 0.01); and weaker grip strength at Waves 1 (p = 0.007) and 2 (p = 0.002). By wave, 
compared to those who remained in the LBC1936 study at Waves 1 to 4,  participants who 
dropped out had: significantly lower older-age IQ scores at Wave 1 (p < 0.001), Wave 2 (p = 
0.001), and Wave 3 ( p = 0.003); lower MMSE scores at Wave 1 (p = 0.04), Wave 2 (p < 
0.001), and Wave 3 ( p = 0.001); lower socio-economic status, represented by less 
professional occupational types, at Wave 1 (p = 0.001), Wave 2 ( p = 0.04), and Wave 3 (p < 
0.001); and lower physical fitness as assessed by lung function at Wave 1 (p < 0.001), Wave 2 
( p = 0.02), and Wave 3 (p = 0.005) and by grip strength at Wave 1 (p = 0.003).   
 
Data for completers only, at baseline and all subsequent waves, are given in Supplementary 
Table 1 (LBC1921) and Supplementary Table 2 (LBC1936).  Comparison of scores from 
completers and those who dropped out at each wave showed that LBC1921 completers scored 
higher at baseline, and consistently across Waves 1 to 4, on the MMSE (all p values < 0.01), 
and higher for physical fitness as assessed by lung function at Wave 1 (p = 0.003). LBC1936 
completers scored higher at baseline, and consistently across Waves 1 to 3, on the MMSE (all 
p values < 0.01), and higher for physical fitness as assessed by grip strength at Wave 1 (p = 
0.03) and by lung function at Waves 1 to 3 (all p values < 0.01).                                
-(Table 3 here)- 
-(Table 4 here)- 
What has been measured?  
The core data collected (cognitive, medical, brain imaging, biomarker, genetic, psycho-social, 
lifestyle, etc.) have been consistent throughout both LBC studies and has remained in the 
protocol for new waves of data collection. At Wave 4 of LBC1921, physical health and 
medical assessments were expanded upon and new self-report data collected. The primary aim 
for LBC1921 Wave 5 was to add magnetic resonance imaging (MRI) of the brain with 
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diffusion tensor and magnetisation transfer imaging (already available in the LBC1936 
sample from Wave 2 onwards) to the cognitive ability data collected at previous waves. A 
sub-sample of LBC1921 participants (n = 42) had previously had structural MRI scans at age 
83. A major aim of LBC1936 Waves 3 and 4 was to use longitudinal brain imaging data to 
examine determinants and consequences of age-related changes in brain structure, and several 
collaborative opportunities also arose during these waves leading to the collection of new 
types of data. New measures are described below and refer to data collection in the LBC1936 
sample unless otherwise stated. A brief overview of each cohort’s measurement protocol and 
new variables measured at each wave is given in Table 1 (LBC1921) and Table 2 (LBC1936). 
Supplementary Table 3 (LBC1921) and Supplementary Table 4 (LBC1936) provide, for the 
first time, comprehensive data grids listing all variables collected throughout both LBC 
studies and the wave at which they were introduced. These are intended to be useful tools for 
would-be collaborators of the LBCs. 
 
New physical, health, and biomedical data 
At LBC1936 Waves 3 and 4, tests of hearing ability by hear-check screener and self-report 
(hearing was assessed in LBC1921 Wave 4), and bioelectrical impedance analysis of body 
composition were added to the protocol. Analysis of blood biomarkers was extended from 
standard haematology and biochemistry to include a larger range of markers of inflammation, 
oxidative stress, and lipoproteins. Additions to the LBC1921 protocol at Wave 4 were hand 
symmetry analysis (hands scanned on digital flatbed scanner) to be used in the measurement 
of fluctuating asymmetry of the body, and musculoskeletal history, including history of 
fractures, joint replacement surgery and diagnosis with osteoarthritis.   
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A brain tissue bank for post-mortem tissue donation was established at Wave 3 of LBC1936 
in collaboration with the Medical Research Council (MRC)-funded University of Edinburgh 
Brain Banks to enable examination of synaptic integrity and axonal structure, and their 
relation to cognitive and other lifetime data. Novel tissue preparation methods and high-
resolution array tomography and electron microscopy imaging techniques will be applied to 
examine human brain synapses at a high level of morphological and molecular detail. To date 
~15% of the original LBC1936 sample have given pre-mortem consent. Stages of post-
mortem analyses from tissue collection to imaging, and details of the first LBC1936 post-
mortem brain tissue analyses are presented in a protocol paper [12]. 
 
At Wave 4 of LBC1936, blood samples were collected and a bank of cells from 420 
participants was formed for the generation of iPSC. The first batch of cells was 
reprogrammed in 2017 as part of a collaboration with the University of Edinburgh’s Centre 
for Regenerative Medicine funded by the MRC via the Dementias Platform UK. These have 
selected 24 participants based on cognitive ageing between childhood and older age, with 
eight samples each of healthy, average, and unhealthy (but not dementia) lifetime cognitive 
ageing.  iPSCs can be reprogrammed to form any tissue type. LBC1936 iPSCs will be 
harnessed for the formation of brain cells (neurons and glia) to test directly the effects of 
environmental challenges on brain tissue, which cannot not be done in vivo. Stem cells from 
the LBC1936 participants have the potential to be used in future collaborative projects and 
experiments examining both pathological and non-pathological ageing and age-related 
neurodegenerative conditions. 
 
New genetic and epigenetic data 
Genome-wide testing of single nucleotide polymorphisms (SNPs) was completed previously 
on the LBCs, using the Illumina 610 quad array. New since the previous profile article [4] is 
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that whole-genome sequencing of over 1300 members of the LBC1921 and LBC1936 was 
funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and the 
data are now available to collaborators. 
 
Using the Illumina Infinium HumanMethylation450 BeadChip, DNA methylation data have 
now been collected from almost every LBC1921 and LBC1936 participant at all waves of 
testing (except LBC1921 Wave 2), with funding from Wellcome, the University of 
Edinburgh, the University of Queensland, and Age UK.  
 
Cell lines from previously-stored LBC1936 blood samples have also been used to examine 
gene expression in a new transcriptomics project funded by The University of Edinburgh. 
Using the Illumina HumanHT-12 v4 Expression BeadChip, genome-wide transcriptional 
coverage has been added to the LBC1936 data at Waves 1 and 3. Thus far, the data have been 
used to examine age-related changes in gene expression and their association with cognitive, 
physical and biochemical traits in older adults [13].  
 
New self-report and lifestyle data 
New questionnaire data have been added to the LBC1936 protocol since 2012.  An adapted 
version of the Pittsburgh Sleep Quality Index [14] was administered at Waves 3 and 4 to 
assess participants’ sleep quality and patterns. Self-reported resilience, measured with the 
Brief Resilience Scale [15], was also recorded at these waves (and LBC1921 Wave 4), as 
were self-reported memory problems.  LBC1921 participants previously provided 
retrospective data on lifetime engagement in physical, leisure and socio-intellectual activities 
[16]; the same questionnaire has since been administered to the LBC1936 following Wave 3. 
The Attitudes to Ageing Questionnaire [17] previously completed at Wave 2 of LBC1936 was 
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administered to LBC1921 at Wave 4. LBC1921 participants completed a qualitative life 
review questionnaire [18] at Wave 4, close to their 90th birthday. It was designed to 
contextualise the cohort in time and place and describe their ‘start in life’, with details on their 
experiences of family and schooling.  
 
Lifetime geographical data 
A ‘life grid’ questionnaire was administered after LBC1936 Wave 3 in which participants 
provided retrospective accounts of all addresses they had lived at throughout their lifetime, as 
well as detailing all occupations held (by themselves and their fathers) since first employment 
to retirement.  As part of the Mobility, Mood and Place project funded by the Engineering and 
Physical Sciences Research Council and in collaboration with University of Edinburgh’s 
Geography Department and the Landscape Architecture Department [19], lifetime address 
data were geo-coded to estimate historical and longitudinal exposure to environmental factors 
such as urban green space and pollution in the Edinburgh area of Scotland, and will be used to 
study the influence of these environmental influences on cognitive ageing. 
 
Objective physical activity data 
A collaborative project, Seniors USP, set up by researchers at Glasgow Caledonian University 
and funded by the Medical Research Council, was initiated at Wave 4 [20, 21]. The project 
aimed to understand the relationship between time spent by older adults sitting (sedentary 
behaviour) and its effect on health, including cognitive function. Self-reported sedentary 
behaviour patterns were recorded in questionnaires and were supplemented by a sedentary 
behaviour diary. Most importantly, objective data were collected: ~7 days of objective data 
were recorded by electronic activity monitor in a subset of ~300 LBC1936 participants. An 
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additional subsample (n=16) who had worn the activity monitor provided qualitative accounts 
of their understanding of sedentary behaviour during semi-structured interview.  
 
New data linkage  
Following completion of dementia ascertainment in the LBC1921 [22], linkages with 
morbidity and mortality were extended to work on dementia ascertainment, chronic disease 
and survival in the LBC1936.  Funded by the Alzheimer Scotland Dementia Research Centre, 
LBC1936 dementia ascertainment is being conducted using various available sources of 
information, to give an indication of the number of participants potentially affected by the 
condition as it becomes more prevalent in the younger cohort. This provides the opportunity 
to study whether there are early signs to predict dementia and to search for risk factors that 
might be associated with the condition.  
 
New scientific aims  
The newly-collected data enhances the wealth of data already collected in the LBC studies. 
Multiple waves of cognitive ability, psycho-social, wellbeing, lifestyle, genetics, other ‘omics, 
brain imaging, physical fitness, and biomedical data add to the historically-recorded and 
retrospectively-recalled life-course data, which means that the studies have the potential to 
address a number of key research questions which go beyond cognitive and brain ageing. For 
example, the LBCs can also be used to examine the nature and determinants of the ageing-
related trajectories of physical and mental health, and wellbeing more broadly. The following 
is a brief indication of some possible analyses. The availability of four waves of LBC1936 
data and five waves of LBC1921 data will allow us and others to investigate the structure and 
determinants of age-related cognitive and brain ageing, including latent growth curve and 
mediation and moderation models. Machine learning methods may be applied in the 
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exploration of cognitive ageing determinants and, combined with forthcoming dementia 
ascertainment data, could allow us to build predictive models of dementia status. New 
biomedical and lifestyle data can contribute to an evidence base for identifying modifiable 
factors that influence ageing, and have the potential to inform interventions to ameliorate the 
detrimental effects of ageing. Whole genome sequencing data, probably as part of a 
consortium, have the potential to further the understanding of the molecular genetic 
contributions to cognitive decline and other important phenotypes. Longitudinal epigenetic 
data may be used to explore associations between epigenetic age acceleration and important 
aspects of ageing such brain and cognitive change, and mood and physical and mental health. 
The LBCs contain assessments of several putative biomarkers of ageing; they can, therefore, 
be used to test how these relate to each other, and whether they make complementary 
contributions to the prediction of cognitive and physical and mental health, and mortality. It 
should be stressed, again, that data available have the potential to answer questions far beyond 
those listed here, and emphatically not limited to cognitive ageing; collaboration and data 
sharing is encouraged. Readers wishing to formulate research ideas are urged to scrutinise 
Supplementary Tables 3 and 4 where there is a fuller list of variables, including measurement 
details, that are available from each wave of the LBC1921 and LBC1936 studies. 
 
What has it found? Key findings and publications 
Together, LBC1921 and LBC1936 data have contributed to about 400 peer-reviewed 
publications. Since the original cohort profile [4], the studies have continued to produce new 
findings in the fields of cognitive ageing and epidemiology. A narrative overview of key 
cognitive and brain ageing results from almost 20 years of research on the LBC studies is 
available elsewhere [23]. Here we give an update on some results published since the 2012 
profile, mainly stemming from new data types or resulting from new longitudinal analyses. 
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Results are discussed according to five main areas of research: cognitive ageing, brain 
imaging, genetics and epigenetics, medical and physical health, and lifestyle. A fuller list of 
publications, including those published between 2012 and 2017 and not reported here, can be 
found on the LBC website (www.lothianbirthcohort.ed.ac.uk).  
 
Cognitive ageing 
Given the unusual separation in time between the original intelligence test at age 11 and 
repeat testing in old age, a central contribution of the LBC studies has been to examine 
intelligence across most of the lifespan. They have demonstrated that childhood cognitive 
ability accounts for ~50% of the variance in cognitive ability in older age [9], and that 
individual differences in intelligence continue to be stable across almost the entire human life 
span, into the tenth decade [10,11].  Continued assessment of cognitive function through the 
eighth (LBC1936), ninth and into the tenth decade (LBC1921), means that the studies are well 
placed to examine the structure of cognitive function within older age [24, 25]. Evidence from 
the LBC1936 indicates that a large proportion of variation in age-related declines across a 
range of cognitive functions is shared: about 50% of the variance in cognitive change on 13 
cognitive subtests was accounted for by a factor of general cognitive change [25]. 
Furthermore, results indicating a strong association between general cognitive change and 
change in speed of basic visual information processing [26] suggest that age-related declines 
in cognitive ability are related to efficiency of perceptual discrimination, as suggested in the 
processing speed theory of cognitive ageing [27].    
 
Repeated collection of cognitive and other phenotypic data has also enabled the cohorts to 
examine putative determinants of cognitive ageing. Many of the variables tested, including 
childhood IQ, have been found to relate only with later life ability levels [25], and not with 
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subsequent trajectories of cognitive decline. In multivariate analyses, possession of the APOE 
e4 allele is one of the few robust independent predictors of relatively greater older-age 
cognitive decline [25]. There is some evidence that physical fitness may be protective against 
decline [25, 16], though physical and cognitive processes in general may be influenced by 
different ageing processes, because evidence for cognitive and physical functions declining in 
tandem is minimal [28].  
 
Brain imaging 
Wave 3 of LBC1936 extended current understanding of the ageing brain through longitudinal 
examination of structural brain imaging data. From Wave 2, the major hypotheses of the 
LBC1936 study were based on a theory of brain white matter disconnection as one of the 
contributors to individual differences in cognitive ageing. Longitudinal analyses showing that 
microstructural integrity of the white matter tracts declines in concert with fluid intelligence 
in older age provided some of the strongest evidence for this theory to date [29]. Other 
structural brain features have also been found to be neuroanatomical contributors of cognitive 
ageing, including cortical thickness [29], volumes of healthy grey and white matter, and 
indicators of small vessel disease [30-33]. LBC1936 data has previously shown that the 
associations between intelligence and brain structure are present across much of the life 
course [30]. New, within-older-age longitudinal results show that cognitive and brain 
structural changes are also related throughout older age. Individuals who score higher on tests 
of memory and information processing speed at age 73 show less subsequent change in total 
brain and white matter volume, and brain volume atrophy due to loss of grey and white matter 
and progression of white matter hyperintensities is modestly associated with declines in 
memory, speed and fluid intelligence between age 73 and 76 years [31].  
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As with cognitive change within older age, predictors of brain structural changes from age 73 
to age 76 have remained elusive, and the effect sizes for significant associations been small. 
In multivariate studies, few predictors of initial brain structure are associated with brain 
structural change, APOE variation and physical fitness differences again being the most 
robust associates [34]. Separate studies using LBC1936 data have indicated: that those 
adhering to a Mediterranean diet have less total brain atrophy between ages 73 and 76 [35]; 
and that vascular risk factors, including poorer glycaemic control (in APOE e4 carriers) [36], 
lower HDL cholesterol [37] and smoking [37, 38], are possibly detrimental to brain health, 
i.e., they are associated with cortical thinning and white matter hyperintensity progression. 
Development of a new biomarker of ‘brain age’ has shown that brain health is important not 
only for cognitive function, but might also be predictive of physical health and survival [39].   
 
Genetics and epigenetics 
Epigenetic (DNA methylation) data have been an important addition to the LBC cohorts’ 
protocols. Variation in epigenetic CpG markers alter gene expression but not the underlying 
DNA sequence and are associated with health outcomes independently of genetic profiles 
[40]. DNA-methylation is susceptible to ageing-related changes. DNA methylation data from 
both cohorts used to calculate ‘biological age’ showed that disparities between ‘biological 
age’ and chronological age (epigenetic age acceleration, or a faster-running ‘epigenetic 
clock’) are related to general bodily fitness and cognitive ability [41], and are predictive of 
mortality [42]. LBC data have contributed to epigenome-wide association studies which have 
found associations between methylation levels and markers of chronic low-grade 
inflammation [43] and BMI [44], and between smoking-related DNA methylation differences 
and genes associated with smoking-related illnesses, such as pulmonary and cardiovascular 
disease, osteoporosis, rheumatoid arthritis and cancer [45].  
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In addition to new epigenetic variables being measured, existing genetic data have been used 
to form new measurement types.  Polygenic risk scores are one example of this. Increased 
polygenic risk for schizophrenia in individuals without the disorder was associated with lower 
fluid-type general cognitive ability at age 70, and greater cognitive decline between age 11 
and 70 years [46]. LBC data have also contributed to polygenic risk studies indicating that 
there may be overlap in genetic variants associated with poorer cognitive ability and coronary 
artery disease [47], and ischemic stroke [48], but not with Alzheimer’s Disease (AD) [49] or 
diabetes [50]. The LBC1936 dataset was used to show that, among those individuals with a 
higher age-11 IQ score, there was a significantly weaker association between the polygenic 
risk score for Type 2 diabetes and HbA1c at age 70 than in those with lower IQ scores [51]. 
Therefore, childhood IQ acts as a moderator of the genetic tendency to type 2 diabetes. 
 
Medical and physical health 
Several biomedical and physical health factors have been studied in relation to cognitive 
ageing between childhood and older age. For future studies, post-mortem examination of 
brain tissue has extended cognitive and brain phenotyping to the level of the synapse [12]. 
Presently, the availability of multiple waves of cognitive data from both cohorts has enabled 
examination of the influence of medical and physical factors on cognitive change within older 
age.  
 
Data from LBC1936 have shown that vascular stiffening, as indexed by increased pulsatility 
and resistivity of the internal carotid artery, but not carotid luminal narrowing, is associated 
with poorer performance on tests of processing speed and visuospatial function and decreased 
crystallised intelligence between the ages of 70 and 76 [52]. However, quantitative 
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microvascular differences assessed from retinal fundus images have shown few associations 
with a range of cognitive abilities, providing limited support for their use as a marker of non-
pathological cognitive ageing [53]. In LBC1936, lower levels of crystallised, visuospatial, 
memory and processing speed ability have also been associated with greater physical frailty in 
older age, and decline in processing speed between the ages of 70 and 76 is also related to 
increased risk of physical frailty onset [54]. 
 
Data from LBC1921 participants has contributed to a study of dementia in the SMS1932 
cohort from which they originated. Results indicated that lower IQ at age 11 is related to 
increased risk of dementia diagnosis between age 65 and 92, an effect which is stronger for 
females than for males [55]. Probable dementia has been ascertained in ~20% of LBC1921; 
positive APOE e4 carrier status and greater participation in physical activity across the life 
course were found to be risk factors for dementia, whereas a history of hypertension and 
increased height may reduce the risk of  dementia diagnosis between ages 79 and 95 [22].   
 
Lifestyle 
Data on current and retrospective levels of engagement in leisure, socio-intellectual and 
physical activity from the LBC1921 study suggests that the importance of different types of 
activities in relation to cognitive ageing may vary across the life course [16]. A study which 
aimed to identify ecological determinants of sedentary behaviour, and included LBC1936 
data, found that being in a carer role was related to lower levels of sedentary behaviour and 
increased sedentary behaviour was related to a fear of crime and perceived absence of 
neighbourhood services [20]. Greater social disadvantage measured using a range of socio-
economic position measures has also been associated with increased time spent sedentary 
amongst retired individuals [21]. Examination of the impact of home and neighbourhood 
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environment on health and cognitive function has expanded from indices of deprivation to 
include the influence of urban space exposure, particularly access to green space, with greater 
access to neighbourhood public parks, particularly in childhood, shown to relate to lower rates 
of cognitive decline in later life [56]. 
 
What are the main strengths and weaknesses? 
An unusual strength of both cohorts is the possession of a valid intelligence test score from 
age 11 years in people who are in older age, and who have taken the same intelligence test 
again throughout older age along with a range of other cognitive and many other tests, 
questionnaires, and diverse assessments. This means that cognitive changes from childhood 
across most of the lifespan can be described and explained, and allows us to test for possible 
confounding or reverse causation between lifetime intelligence and putative determinants of 
cognitive ageing, whereby apparent determinants of individual differences in cognitive ageing 
(such as lifestyle factors) are themselves predicted by differences in intelligence measured in 
childhood. Key examples of confounding or reverse causation in LBC1936 include diet [57], 
diabetes [58] and participation in intellectual activities [59], with associations between each 
of these variables and older-age cognitive ability being confounded by prior IQ. Combined 
with structural brain imaging in both cohorts, the studies have the ability to examine the 
biological foundations of cognitive function throughout most of older age. It is also a strength 
that both LBC studies are narrow age cohorts, which means that the variables measured 
reflect differential ageing and not chronological age, which can otherwise swamp the variance 
in assessments and inflate effect sizes. With there being two LBC cohorts, born 15 years 
apart, and tested on the same childhood intelligence test and on many similar variables at the 
same older age (79 years), it is possible to perform some tests of cohort differences. This will 
be done by matching the LBC1921 and LBC1936 on key background variables and then 
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testing for differences in outcomes of interest. The prospective data collection from a variety 
of sources on a broad range of putative determinants and outcomes, many of which are 
repeated at multiple waves, means that both cohorts are rich sources of data.  
Weaknesses of the LBCs include the limited sample sizes of the two cohorts, their being 
somewhat restricted in range with respect to childhood intelligence and childhood and adult 
socio-economic status, and there being several decades without data collection between 
participants sitting the MHT at age 11 and the LBC studies being initiated when they were 
aged 70 (LBC1936) and 79 (LBC1921). The mean (SD) Moray House Test score at age 11 
was:  46.4 (12.1) for the LBC1921 compared with 34.5 (15.5) for the whole of Scotland; and 
49.0 (11.8) for the LBC1936 compared with 36.7 (16.1) for the whole of Scotland, and a 
mean of 40.3 for the Edinburgh region. However, the reports on the samples are able—
because the whole populations were tested at age 11—to estimate accurately by how much 
these factors might attenuate effect sizes. Longitudinal attrition has resulted in some sampling 
bias, such that those who continue to participate in testing are more cognitively and physically 
able to do so, though this can be addressed using up-to-date statistical techniques. Both 
cohorts are also limited by being entirely composed of Caucasian participants.  
 
Can I get hold of the data? Where can I find out more? 
The LBCs’ study data have been the subject of many internal (within the University of 
Edinburgh) and external collaborations, which are encouraged. Those who have interests in 
outcomes other than cognitive domains are particularly encouraged to collaborate. The current 
procedure for those who wish to work with the data is initially to email the Lothian Birth 
Cohorts Director Professor Ian Deary to ask for a ‘LBC Data Request Form’. Comprehensive 
data grids listing all variables collected throughout both LBC studies and the wave at which 
they were introduced are provided in Supplementary tables 3 and 4, and both LBC studies 
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have clear data dictionaries which help researchers to discern whether the variables they wish 
to use are present; these provide a simple short title for each variable, alongside a longer, 
common-sense description/provenance of each variable. The process is facilitated by a full-
time LBC database manager. Such proposals, when approved, are conducted in collaboration 
with appropriate members of the LBC study team. 
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Lothian Birth Cohorts (LBCs) in a nutshell  
- The LBCs originated as follow-ups to the Scottish Mental Surveys of 1932 (SMS1932) 
and 1947 (SMS1947) which tested childhood intelligence in Scotland.  
- The Lothian Birth Cohorts of 1921 (LBC1921: N = 550, beginning at age 79) and 1936 
(LBC1936: N = 1091, beginning at age 70) began in 1999 and 2004 respectively, 
principally to study determinants of non-pathological cognitive ageing. 
- Both cohorts have been followed up at ~3 yearly intervals. New waves of data have been 
collected since the previous LBCs’ profile. The most recent waves were completed in 
2013 (LBC1921 Wave 5: n = 59, age 92) and 2017 (LBC1936 Wave 4: n = 550, age 79). 
- A broad range of cognitive, psycho-social, brain imaging, medical, physical, genetic, 
lifestyle, and other variables have been collected longitudinally.  
- New measures since the previous LBCs’ cohort profile include: whole genome 
sequencing, longitudinal DNA methylation, longitudinal gene expression, lipidomics, 
sedentary patterns analysis, inducible pluripotent stem cells (iPSC), historical 
environmental exposures, post-mortem brain tissue, dementia ascertainment (LBC1936), 
and several new biomarkers and questionnaire assessments.  
- The cohorts have several existing collaborations. For enquiries regarding new 
collaborative opportunities and data sharing please contact the LBCs’ study Director Ian 
Deary (i.deary@ed.ac.uk). 
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Table 1. The Lothian Birth Cohort of 1921 (LBC1921) 
 
Participants of LBC1921 were originally tested on the Moray House Test No.12 intelligence test as part of the Scottish Mental Survey 1932 (N=87,498) at a mean age of 10.9 
years (SD=0.3).  
 
Table key: 
  = data available at time of previous cohorts profile publication 
  = new wave of data, repeat collection of previous variable 
  = new variable not previously collected 
 
Variable measured  
Wave 1 
1999-2001 
79.1 years (sd=0.6) 
N (m/f) = 550 
(234/316) 
Wave 2 
2003-2005 
83.4 years (sd=0.5) 
N (m/f) = 321 
(145/176) 
Wave 3 
2007-2008 
86.6 years (sd=0.4) 
N (m/f) = 237 
(109/128) 
Wave 4 
2011-2012 
90.1 years (sd=0.1) 
N (m/f) = 140 
(62/78) 
Wave 5 
2013 
92.1 years (sd=0.3) 
N (m/f) = 59 
(26/33) 
Cognitive ability      
Moray House Test No. 12       
Cognitive test battery (executive function, reasoning and 
memory) 
     
Processing speed measures      
Social and demographic data      
Includes: residence, childhood overcrowding/deprivation, 
education, occupation 
     
Marital status       
Questionnaires      
Includes: family, loneliness, social support, activities, wellbeing, 
personality 
     
Includes: children, employment, religious activity, and spiritual 
wellbeing 
     
Neighbourhood questions, Life Orientation Test-Revised, Sense 
of Coherence  
     
Warwick-Edinburgh Mental Wellbeing Scale       
The Brief Resilience Scale, Attitudes to Ageing Questionnaire, 
Life review 
     
Physical and Medical      
Various including: smoking, alcohol, physical fitness, disease 
history, medication, blood pressure, height, weight    
     
Visual acuity      
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Demi-span, dentition, electrocardiogram       
Head circumference       
Facial symmetry analysis      
Fluctuating asymmetry, ankle-brachial pressure index       
Self-rated health      
Hand asymmetry analysis, musculoskeletal history, hearing      
Family history of disease      
Biochemistry, haematology, inflammation and oxidative stress      
Various including full blood count, coagulation screening and 
glycated haemoglobin  
     
Triglyceride, Total serum cholesterol      
Vitamin B12, red cell folate, thyroid stimulating hormone, 
thyroxine 
     
Serum folate,      
PT ratio,  APTT ratio, D-Dimer, urea, estimated glomerular 
filtration rate, C-reactive protein  
     
Sodium, potassium, albumin      
Tumor necrosis factor alpha       
Von Willebrand Factor, interleukin 6       
Trolox equivalent antioxidant capacity, DNA damage, 
antioxidant vitamins 
     
Genetic analysis      
Apolipoprotein E genoptyping, Genome-wide genotyping, Whole 
genome sequencing 
     
Telomere length      
DNA methylation      
Brain magnetic resonance imaging (MRI)      
Structural brain MRI measures (various; sub-sample n = 42)      
Diffusion tensor derived long-range tract variables, volume 
measures, visual atrophy and lesion rating, Desikan-Killiany 
Atlast Parcellation (FreeSurfer), neuroradiological report 
    
 
Retinal imaging      
Microvascular widths and branching geometry      
Linkages      
Date and cause of death, dementia diagnosis      
Morbidity      
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Table 2. Data available and planned for Lothian Birth Cohort 1936(LBC1936) 
 
Participants of LBC1936 were originally tested on the Moray House Test No.12 intelligence test as part of the Scottish Mental Survey 1947 (N=70,805) at a mean age of 10.9 
years (SD=0.3).  
 
Table key 
Data available: 
 = data available at previous cohort profile publication (2012) 
 = new data wave, repeat of previous variable 
 = new variable not previously collected 
Forthcoming data:  
 = planned for Wave 5, repeat of previous variable 
 = new variable forthcoming, not previously collected 
 
Variable measured 
Wave 1 
2004-2007 
69.5 years (sd=0.8) 
N (m/f) = 1091 
(548/543) 
Wave 2 
2007-2010 
72.5 years (sd=0.7) 
N (m/f) = 866 
(448/418) 
Wave 3 
2011-2013 
76.3 years (sd=0.7) 
N (m/f) = 697 
(360/337) 
Wave 4 
2014-2017 
79.3 years (sd=0.6) 
N (m/f) = 550 
(275/275) 
Wave 5a 
2017-2019 
~82 years  
N = ~440 
Cognitive ability      
Moray House Test No. 12       
Cognitive test battery      
‘Frontal’ function tests (sub-sample n =90)      
Test of Premorbid Functioning, Trail Making Test (Part B)      
Raven’s Progressive Matrices      
Financial literacy and competence      
Social and demographic data      
Various including: age,  marital status, residence       
Various including: deprivation, education, occupation, retirement       
Current employment status, volunteering and caring       
Questionnaires      
Various including: personality, quality of life, social support      
Various including: personality, loneliness       
Physical activity level, sport/exercise, intellectual/social activities       
Food Frequency Questionnaire       
Various including: social support, satisfaction with life, wellbeing       
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Sense of coherence, personal and social wellbeing       
Attitudes to Ageing Questionnaire, health literacy, bilingualism      
Various including: lifetime addresses, lifetime activity      
The Brief Resilience Scale, self-reported memory problems      
Sleep quality and pattern       
Various including: apathy, sedentary patterns, social desirability      
Musical experience and expertise      
Physical and Medical      
Various including: smoking, alcohol, disease history, medication, 
height, weight, visual acuity, blood pressure, physical fitness 
     
Self-rated health, dentition, stand tests       
Head circumference, menopause       
Ankle-brachial pressure index      
Facial symmetry photographs      
Salt intake, bioelectrical impedance analysis      
Hearing       
Incidence of falls      
Sedentary behaviour analysis by electronic activity monitor      
Biochemistry and haematology analysis      
Various including: full blood count, coagulation, cholesterol      
Various including: D-Dimer, eGFR, iron, urine analysis      
Red cell folate      
Urate       
Sex hormone-binding globulin, testosterone      
Free androgen index      
International normalised ratio warfarin      
Inflammation markers      
High sensitivity CRP,  Von Willebrand Factor,  interleukin 6      
Various including: cystatin C, lipoprotein A, vitamin D      
Oxidative Stress      
Urinary-8 Isoprostane, trolox equivalent antioxidant capacity       
DNA damage, antioxidant vitamins      
Blood Brain Barrier      
S100 beta      
Saliva analysis      
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aWave 5 in progress from October 2017: age & N are estimates based on attrition at previous waves. 
 
DNA (if unable to obtain blood sample only)      
Cortisol (subsample n = 90)      
Immunology      
Cytomegalovirus (CMV) serostatus and titre      
iPSC stem cell reprogramming      
Peripheral blood mononuclear cell samples taken      
Brain tissue analysis      
Pre-mortem consent      
Genetic analysis      
Telomere length      
Apolipoprotein E genotyping, Genome-wide genotyping      
DNA methylation      
Transcriptome-wide gene expression      
Whole genome sequencing      
Brain magnetic resonance imaging (MRI)      
Various including: DT-tracts, volumes, atrophy/lesion rating      
Whole brain structural connectome      
Carotid Doppler ultrasound      
Velocities, stenosis, intima-media thickness       
Retinal imaging       
Microvascular branching geometry, fractal dimension, tortuosity       
Linkages      
Date and cause of death, hospital discharge diagnosis      
Dementia diagnosis      
Medical prescription data      
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Table 3. Sample characteristics at each wave by returning status in the Lothian Birth Cohort 1921 
 
VARIABLE 
Wave 1 
(n = 550) 
Dropout 
W1 
(n = 231) 
Wave 2 
(n = 321c) 
Dropout 
W2 
(n = 88) 
Wave 3 
(n = 235d) 
Dropout 
W3 
(n = 106) 
Wave 4 
(n = 129) 
Dropout 
W4 
 (n = 70) 
Wave 5 
(n = 59) 
Sex (male) 42.5% 39% 45.2% 40.4% 46.4% 47.2% 45.7% 47.1% 44.1% 
Age-11 IQ 100.0 (15.0) 98.6 (15.6) 101.0 (14.5) 99.4 (15.1) 101.6 (14.2) 99.9 (15.2) 103.0 (13.2) 104.3 (13.9) 101.4 (12.2) 
Age-79 IQ 100.0 (15.0) 96.8 (16.3) 102.3 (13.6) 98.7 (14.5) 103.7 (12.9) 101.3 (14.3) 105.5 (11.4) 106.6 (11.0) 104.3 (11.7) 
MMSE 28.2 (1.69) 27.9 (1.92) 28.1 (1.94) 27.4 (2.40) 27.8 (2.31) 27.1 (2.91) 27.3 (2.93) 26.7 (3.64) 27.2 (2.36) 
Father’s SES 2.73 (0.93) 2.80 (0.92) 2.69 (0.94) 2.72 (0.84) 2.68 (0.97) 2.70 (0.79) 2.66 (1.10) 2.53 (1.01) 2.81 (1.18) 
Participant SES 2.24 (0.88) 2.37 (0.94) 2.15 (0.83) 2.26 (0.80) 2.11 (0.83) 2.20 (0.75) 2.04 (0.89) 1.90 (0.81) 2.20 (0.96) 
CVD(yes)a 29.5% 28.6% 15.9% 13.5% 20.0% 18.9% 45% 45.7% 50.8% 
Grip strengthb 26.5 (9.11) 25.3 (8.42) 24.9 (9.19) 22.5 (8.00) 21.5 (8.77) 20.2 (8.40) 20.3 (8.16) 19.7 (8.58) 17.9 (9.11) 
FEV1 1.88 (0.62) 1.77 (0.63) - - 1.77 (0.56) 1.70 (0.52) 1.66 (0.55) 1.62 (0.57) 1.53 (0.54) 
Note. Values given are mean and standard deviation, except for sex and CVD, for each wave sample split by returning status:  Dropout W1 = 
completed Wave 1 only; Dropout W2 = completed Waves 1 & 2 only; Dropout W3 = completed Waves 1, 2 & 3 only; Dropout W4 = completed 
Waves 1-4 only. IQ calculated from Moray House Test score corrected for age in days at time of testing and converted to IQ scale. MMSE = 
Mini-Mental State Examination. Father’s SES (= socio-economic status) is participant’s father’s social class when the participant was aged 11 (5 
categories from professional (1) to unskilled labour (5)). CVD = cardiovascular disease. FEV1 = forced expiratory volume from the lungs in one 
second. 
a CVD includes unsure and angina only at Wave 1 
b Grip strength reported as best of three from the right hand.   
c Wave 2 includes 2 participants who did not attend Wave 1 
d Wave 3 includes 2 participants who attended Wave 1 but not Wave 2 
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Table 4. Sample characteristics at each wave by returning status in the Lothian Birth Cohort 1936 
 
Variable Wave 1 
( N = 1091) 
Dropout W1 
(N = 225) 
Wave 2 
(N = 866) 
Dropout W2 
(N = 169) 
Wave 3 
(N = 697) 
Dropout W3 
(N = 158) 
Wave 4 
(N = 550b) 
Sex (male) 50.2% 44.4% 51.7% 52.1% 51.6% 55.7% 50% 
Age-11 IQ 100.0 (15.0) 99.8 (14.4) 100.0 (15.1) 99.3 (16.1) 100.2 (14.9) 100.0 (14.9) 100.0 (15.0) 
Age-70 IQ 100.0 (15.0) 96.1 (16.9) 101.0 (14.3) 97.6 (16.0) 101.8 (13.8) 98.7 (14.6) 102.5 (13.7) 
MMSE 28.8 (1.43) 28.6 (1.57) 28.8 (1.42) 28.3 (1.76) 28.7 (1.70) 28.2 (2.11) 28.5 (2.16) 
Father’s SES 2.91 (0.94) 2.87 (0.94) 2.92 (0.94) 3.02 (0.95) 2.89 (0.94) 2.94 (0.89) 2.88 (0.95) 
Participant SES 2.40 (0.91) 2.58 (0.86) 2.36 (0.92) 2.49 (0.88) 2.33 (0.93) 2.59 (0.90) 2.26 (0.92) 
CVD (yes) 24.6% 27.6% 28.9% 30.2% 33.9% 32.3% 37.1% 
Grip strengtha 29.0 (10.1) 27.2 (10.6) 28.7 (9.45) 27.5 (9.40) 27.7 (10.1) 27.4 (11.0) 26.1 (9.43) 
FEV1 2.36 (0.69) 2.15 (0.67) 2.30 (0.68) 2.19 (0.64) 2.11 (0.64) 1.98 (0.62) 2.11 (0.64) 
Note. Values given are mean and standard deviation, except for sex and CVD, for each wave sample split by returning status:  Dropout W1 = 
completed Wave 1 only; Dropout W2 = completed Waves 1 & 2 only; Dropout W3 = completed Waves 1, 2 & 3 only. IQ calculated from Moray 
House Test score corrected for age in days at time of testing and converted to IQ scale. MMSE = Mini-Mental State Examination. Father’s SES 
(= socio-economic status) is participant’s father’s social class when the participant was aged 11 (5 categories from professional (1) to unskilled 
labour (5)). CVD = cardiovascular disease. FEV1 = forced expiratory volume from the lungs in one second. 
a Grip strength reported as best of three from the right hand.   
b Wave 4 includes 11 participants who did not attend Wave 3. 
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Figure 1. Waves of testing and attrition between waves in the LBC1921 study 
 
 
 
 
Wave 4 
N=129  
(+11 with dementia) 
Mean age (SD) = 90.1 (0.1) 
Wave 3 
N=235 
Mean age (SD) = 86.6 (0.4) 
Wave 2 
N=321 
Mean age (SD) = 83.4 (0.5) 
229 participants lost (41.6% of Wave 1): 
88 Died 
60 Withdrew 
54 Not well enough/no longer eligible 
9 Lost contact 
18 Other reasons 
86 participants lost (26.8% of Wave 2): 
55 Died 
7 Withdrew 
19 Not well enough/no longer eligible 
5 Lost contact 
95 participants lost (40.4% of Wave 3):  
47 Died 
6 Withdrew 
32 Not well enough/no longer eligible 
1 Lost contact 
9 Other reasons 
70 participants lost (54.3% of Wave 4):  
18 Died 
2 Withdrew 
31 Wave 4 home visits excluded 
13 Not well enough/no longer eligible 
1 Lost contact 
5 Other reasons 
 
Wave 5 
N=59  
Mean age (SD) = 92.1 (0.3) 
 
 
Wave 1 
N=550 
Mean age (SD) = 79.1 (0.6) 
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Figure 2. Waves of testing and attrition between waves in the LBC1936 study 
 
 
Wave 3 
N = 697 
Mean age (SD) = 76.3 (0.7) 
 
 
Wave 2 
N = 866 
Mean age (SD) = 72.5 (0.7) 
 
225 participants lost (20.6% of Wave 1): 
39 Died 
151 Withdrew 
13 Not well enough/no longer eligible  
19 Lost contact 
3 Other reasons 
 
169 participants lost (19.5% of Wave 2): 
38 Died 
96 Withdrew 
18 Not well enough / no longer eligible 
8 Lost contact 
9 Other reasons 
 
Wave 4 
N = 550 
Mean age (SD) = 79.3 (0.6) 
 
 
147 participants lost (21.1% of Wave 3): 
40 Died 
72 Withdrew 
21 Not well enough / no longer eligible 
9 Lost contact 
5 Other reasons 
 
Wave 1 
N = 1091 
Mean age (SD) = 69.5 (0.8) 
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